Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.

van Helden, E J; Elias, S G; Gerritse, S L; van Es, S C; Boon, E; Huisman, M C; van Grieken, N C T; Dekker, H et al. · Eur J Nucl Med Mol Imaging · 2020

Where this comes from

Record sourced from PubMed, PMID 32535653.
Also identified by DOI 10.1007/s00259-020-04908-6 and PMC identifier 7645532.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

Missing Electronic Supplementary Materials.

Read the full text

View on PubMed · Publisher (DOI)